We are live on
!
Find out more
LCG
Lisanti Capital Growth Portfolio holdings
AUM
$455M
1-Year Est. Return
218.66%
This Fund
S&P 500
This Quarter
Est. Return
+66.19%
1 Year Est. Return
+218.66%
3 Year Est. Return
+1,489.77%
5 Year Est. Return
+4,348.98%
10 Year Est. Return
+169,910.37%
AUM
$455M
AUM Growth
+$57.7M
(+15%)
Cap. Flow
-$82.2M
Cap. Flow
% of AUM
-18.09%
Top 10 Holdings %
Top 10 Hldgs %
19.06%
Holding
153
New
50
Increased
18
Reduced
37
Closed
44
Avg Time Held
1.8
quarters
Top 10 Avg Time Held
0.3
quarters
Top 20 Avg Time Held
0.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xometry
XMTR
|
+$7.21M |
| 2 |
Crocs
CROX
|
+$5.77M |
| 3 |
Corcept Therapeutics
CORT
|
+$5.53M |
| 4 |
Commault Systems
CVLT
|
+$5.33M |
| 5 |
EquipmentShare.com Inc
EQPT
|
+$5.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sterling Infrastructure
STRL
|
+$10.7M |
| 2 |
Five Below
FIVE
|
+$9.74M |
| 3 |
Patterson-UTI
PTEN
|
+$9.71M |
| 4 |
Matador Resources
MTDR
|
+$7.78M |
| 5 |
Advanced Energy
AEIS
|
+$7.66M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.16% |
| 2 | Healthcare | 25.57% |
| 3 | Industrials | 23.22% |
| 4 | Consumer Discretionary | 9.43% |
| 5 | Financials | 2.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Hinge Health
HNGE
$8.43B
| $11.5M | 2.54% |
139,150
+79,950
| +135% | +$4.34M |
2025 Q2
4 quarters
|
|
2
BrightSpring Health Services
BTSG
$12.3B
| $10.8M | 2.37% |
154,620
-34,835
| -18% | -$1.93M |
2025 Q3
3 quarters
|
|
|
3
Xometry
XMTR
$6.22B
| $9.74M | 2.14% |
+100,880
| New | +$7.21M |
2026 Q2
0 quarters
|
|
4
Solaris Energy Infrastructure
SEI
$5.08B
| $9.23M | 2.03% |
114,745
-2,570
| -2% | -$184K |
2025 Q4
2 quarters
|
|
|
5
Corcept Therapeutics
CORT
$12.8B
| $7.97M | 1.75% |
+91,610
| New | +$5.53M |
2026 Q2
0 quarters
|
|
6
DigitalOcean
DOCN
$15.1B
| $7.92M | 1.74% |
50,425
-18,800
| -27% | -$2.54M |
2025 Q4
2 quarters
|
|
7
Allegro MicroSystems
ALGM
$6.21B
| $7.51M | 1.65% |
+107,865
| New | +$5.05M |
2026 Q2
0 quarters
|
|
8
Mirum Pharmaceuticals
MIRM
$5.26B
| $7.41M | 1.63% |
63,295
+24,290
| +62% | +$2.44M |
2026 Q1
1 quarter
|
|
9
JFrog
FROG
$12.4B
| $7.33M | 1.61% |
80,655
-38,655
| -32% | -$2.51M |
2025 Q1
5 quarters
|
|
10
Carpenter Technology
CRS
$18.7B
| $7.2M | 1.58% |
11,665
-9,310
| -44% | -$4.38M |
2024 Q2
8 quarters
|
|
11
Dycom Industries
DY
$8.16B
| $7.16M | 1.58% |
14,170
-2,835
| -17% | -$1.24M |
2025 Q2
4 quarters
|
|
12
Krystal Biotech
KRYS
$9.6B
| $7.08M | 1.56% |
19,050
+535
| +3% | +$160K |
2026 Q1
1 quarter
|
|
|
13
Commault Systems
CVLT
$6.47B
| $7.04M | 1.55% |
+49,640
| New | +$5.33M |
2026 Q2
0 quarters
|
|
14
Adaptive Biotechnologies
ADPT
$4.09B
| $6.97M | 1.53% |
+325,155
| New | +$4.98M |
2026 Q2
0 quarters
|
|
15
Zeta Global
ZETA
$8.62B
| $6.92M | 1.52% |
351,415
+200,480
| +133% | +$3.72M |
2024 Q3
7 quarters
|
|
16
RBC Bearings
RBC
$16.2B
| $6.78M | 1.49% |
10,531
-2,215
| -17% | -$1.32M |
2025 Q1
5 quarters
|
|
17
Travere Therapeutics
TVTX
$4.88B
| $6.76M | 1.49% |
119,005
+70,820
| +147% | +$3.14M |
2025 Q3
3 quarters
|
|
18
Enova International
ENVA
$4.32B
| $6.66M | 1.46% |
27,655
+1,815
| +7% | +$312K |
2025 Q4
2 quarters
|
|
19
FormFactor
FORM
$9.85B
| $6.63M | 1.46% |
41,430
+12,125
| +41% | +$1.61M |
2026 Q1
1 quarter
|
|
20
Ultra Clean Holdings
UCTT
$2.7B
| $6.6M | 1.45% |
46,285
-13,550
| -23% | -$1.19M |
2026 Q1
1 quarter
|
|
21
Palvella Therapeutics
PVLA
$1.86B
| $6.57M | 1.44% |
42,975
+1,530
| +4% | +$186K |
2025 Q4
2 quarters
|
|
22
Silicon Motion
SIMO
$8.29B
| $6.53M | 1.44% |
19,600
-5,685
| -22% | -$1.32M |
2026 Q1
1 quarter
|
|
23
Modine Manufacturing
MOD
$9.18B
| $6.4M | 1.41% |
23,975
-13,290
| -36% | -$3.5M |
2026 Q1
1 quarter
|
|
|
24
Crocs
CROX
$5.65B
| $6.37M | 1.4% |
+52,840
| New | +$5.77M |
2026 Q2
0 quarters
|
|
25
Guardian Pharmacy Services
GRDN
$2.52B
| $6.37M | 1.4% |
152,025
-36,125
| -19% | -$1.4M |
2026 Q1
1 quarter
|
|
Similar funds
HFA
BI
PIM
GA
MI
MC
CFO
IIA
Lisanti Capital Growth's Q2 2026 Portfolio in Review
As of Q2 2026, Lisanti Capital Growth held 153 positions worth $455M, up 15% from $397M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Lisanti Capital Growth withdrew a net $82.2M in Q2 2026, closing 44 positions and reducing 37 holdings. Its most notable exit was Five Below, an estimated $9.74M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Lisanti Capital Growth opened a new position in Xometry worth $9.74M.
- Lisanti Capital Growth's largest Q2 2026 buy was Xometry: 100,880 shares worth $9.74M.
- Lisanti Capital Growth added most to Hinge Health in Q2 2026, an estimated $4.34M increase.
- Lisanti Capital Growth's biggest Q2 2026 reduction was Sterling Infrastructure, cutting an estimated $10.7M.
- Lisanti Capital Growth fully exited Five Below in Q2 2026, selling an estimated $9.74M.
- Lisanti Capital Growth's ten largest holdings make up 19% of its $455M portfolio in Q2 2026.
- Lisanti Capital Growth opened 50 new positions and closed 44 in Q2 2026.
- Lisanti Capital Growth's portfolio value rose 15% quarter-over-quarter to $455M.
Based on Lisanti Capital Growth's 13F filing for Q2 2026, filed 10 Aug 2026.